Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Digital Health Literacy and Oocyte Cryopreservation Among Women With Gynecological Cancer

8. Juli 2026 aktualisiert von: Eman Atef Elsokary, Benha University

Digital Health Literacy and Oocyte Cryopreservation: Perspectives of Newly Diagnosed Gynecological Cancer Women

This study evaluated a digital health literacy education intervention related to oocyte cryopreservation among newly diagnosed women with gynecological cancer. A quasi-experimental single-group pre-post design was used at the Outpatient Clinics of the Oncology Center, Mansoura University Hospital, Egypt. A purposive sample of 158 women participated. Outcomes were measured before and after the intervention and included knowledge about oocyte cryopreservation, attitudes toward oocyte cryopreservation, and decisional conflict. The intervention used videos, images, WhatsApp, Zoom, Microsoft Teams, PowerPoint slides, short text messages, simple Arabic-language educational materials, and follow-up through phone or social media when needed. Outcomes were reassessed at the end of week 4.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

Newly diagnosed women with gynecological cancer may face fertility-related concerns before starting cancer treatment. This study assessed whether a digital health literacy education intervention related to oocyte cryopreservation could improve women's knowledge, attitudes, and decisional conflict.

The study used a quasi-experimental single-group pre-post design. It was conducted at the Outpatient Clinics of the Oncology Center at Mansoura University Hospital, Dakahlia Governorate, Egypt. The study included 158 newly diagnosed women with gynecological cancer selected using purposive sampling.

Eligible participants were women aged 18 to 45 years who were newly diagnosed with gynecological cancer, had not received cancer treatment, had not received cryopreservation instructions before, and had access to a smartphone, internet connection, and social media. Women who had received chemotherapy, radiotherapy, or hormonal therapy, or who had learning difficulties such as dementia or vision impairment, were excluded.

were women Baseline data were collected using a structured interview questionnaire and study tools assessing knowledge about gynecological cancer and oocyte cryopreservation, attitudes toward oocyte cryopreservation, and decisional conflict. The digital health literacy intervention was delivered using videos, visually engaging images, WhatsApp groups, Zoom and Microsoft Teams meetings, PowerPoint slides, short text messages, interactive visuals and animations, simple Arabic language, and instructive pictures. The educational content covered general information about gynecological cancer and fertility, fertility preservation options, and detailed information about oocyte cryopreservation, including definition, indications, advantages, benefits, and process steps. Content also included embryo cryopreservation, ovarian tissue cryopreservation, fertility-sparing surgery, and ovarian transposition.

Four sessions were delivered, with 20 women per group. Each session was held three days per week on Sunday, Tuesday, and Thursday and lasted 30 to 45 minutes. Follow-up was conducted by phone or social media as needed to reinforce planning and address barriers. Outcomes were reassessed at the end of week 4 using the same instruments.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

158

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

  • Ägypten
    • Dakahlia Governorate
      • Al Mansurah, Dakahlia Governorate, Ägypten
        • Oncology Center, Mansoura University Hospital

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

  • Newly diagnosed women with gynecological cancers who had not received any treatment.
  • Women of reproductive age, 18-45 years.
  • Women with gynecological cancers who had not received cryopreservation instructions before.
  • Women who had a smartphone, internet connection, could use social media, and had access to the internet through their phone.

Exclusion Criteria:

  • Women with gynecological cancer who had received cancer treatment, including chemotherapy, radiotherapy, or hormonal therapy.
  • Women diagnosed with learning difficulties, such as dementia or vision impairment.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: N / A
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Digital Health Literacy Intervention
Participants received a digital health literacy education intervention related to oocyte cryopreservation. Outcomes were measured before and after the intervention.
Verhalten: Digital Health Literacy Education Intervention
The intervention included videos, visually engaging images, WhatsApp groups, Zoom and Microsoft Teams meetings, PowerPoint slides, short text messages, interactive visuals/animations, simple Arabic-language educational materials, and instructive pictures. The educational content covered general information about gynecological cancer and fertility, fertility-preservation options, and detailed information about oocyte cryopreservation, including definition, indications, advantages/benefits, and process/steps. Content also included embryo cryopreservation, ovarian tissue cryopreservation, fertility-sparing surgery, and ovarian transposition. Follow-up was conducted by phone or social media as needed.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Knowledge Regarding Oocyte Cryopreservation
Zeitfenster: Pre-intervention and end of week 4
Knowledge regarding oocyte cryopreservation was assessed using the Oocyte Cryopreservation Knowledge Questionnaire. The questionnaire included 20 multiple-choice questions covering general information about gynecological cancer and fertility, fertility preservation options, and oocyte cryopreservation. Each correct answer was scored 1 and each incorrect or "don't know" answer was scored 0. The total score ranged from 0 to 20, with higher scores indicating higher knowledge. Scores of 60% or higher were classified as satisfactory knowledge.
Pre-intervention and end of week 4
Change in Attitude Toward Oocyte Cryopreservation
Zeitfenster: Pre-intervention and end of week 4
Attitude toward oocyte cryopreservation was assessed using an attitude scale developed by the researchers after reviewing the literature. The scale included 15 statements: 11 positive statements and 4 negative statements. Responses were scored using a three-point Likert scale: agree = 2, uncertain = 1, and disagree = 0. Negatively worded items were reverse scored. The total score ranged from 0 to 30, with higher scores indicating a more positive attitude toward oocyte cryopreservation. Scores of 70% or higher were classified as positive attitude.
Pre-intervention and end of week 4
Change in Decisional Conflict Regarding Oocyte Cryopreservation
Zeitfenster: Pre-intervention and end of week 4
Decisional conflict regarding oocyte cryopreservation was assessed using the 16-item Decisional Conflict Scale. Items were organized into five domains related to feeling informed, value clarification, support, uncertainty, and effective decision-making. Responses were scored on a five-point scale from strongly agree to strongly disagree. The total score ranged from 0 to 100, with higher scores indicating greater decisional conflict. Scores less than 25 indicated low decisional conflict, scores between 25 and 37.5 indicated moderate decisional conflict, and scores above 37.5 indicated high decisional conflict.
Pre-intervention and end of week 4

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Benha University

Mitarbeiter

Mansoura University

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. September 2025

Primärer Abschluss (Tatsächlich)

30. März 2026

Studienabschluss (Tatsächlich)

30. März 2026

Studienanmeldedaten

Zuerst eingereicht

8. Juli 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

8. Juli 2026

Zuerst gepostet (Tatsächlich)

14. Juli 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

14. Juli 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

8. Juli 2026

Zuletzt verifiziert

1. Juli 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Schlüsselwörter

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • IRB00000844

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

Data supporting the study findings will be available upon reasonable request from the corresponding author.

IPD-Sharing-Zeitrahmen

Available upon reasonable request after publication.

IPD-Sharing-Zugriffskriterien

Researchers may request access to the data from the corresponding author.

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Digital Health Literacy Education Intervention

Suchen Sie nach ähnlichen Studien

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

CROs by country

CROs in Hong Kong

Bedingungen

Seltene Krankheiten

Drogeninterventionen

Nahrungsergänzungsmittel

Sponsor / Mitarbeiter

Standorte

3
Abonnieren